AU2001278987A1 - A systematic approach to mechanism-of-response analyses - Google Patents

A systematic approach to mechanism-of-response analyses

Info

Publication number
AU2001278987A1
AU2001278987A1 AU2001278987A AU7898701A AU2001278987A1 AU 2001278987 A1 AU2001278987 A1 AU 2001278987A1 AU 2001278987 A AU2001278987 A AU 2001278987A AU 7898701 A AU7898701 A AU 7898701A AU 2001278987 A1 AU2001278987 A1 AU 2001278987A1
Authority
AU
Australia
Prior art keywords
systematic approach
response analyses
analyses
response
systematic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278987A
Inventor
Joseph A. Monforte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Althea Inc
Original Assignee
Althea Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Althea Technologies Inc filed Critical Althea Technologies Inc
Publication of AU2001278987A1 publication Critical patent/AU2001278987A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
AU2001278987A 2000-07-21 2001-07-20 A systematic approach to mechanism-of-response analyses Abandoned AU2001278987A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22008000P 2000-07-21 2000-07-21
US60/220,080 2000-07-21
PCT/US2001/023074 WO2002008466A1 (en) 2000-07-21 2001-07-20 A systematic approach to mechanism-of-response analyses

Publications (1)

Publication Number Publication Date
AU2001278987A1 true AU2001278987A1 (en) 2002-02-05

Family

ID=22821963

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278987A Abandoned AU2001278987A1 (en) 2000-07-21 2001-07-20 A systematic approach to mechanism-of-response analyses

Country Status (5)

Country Link
US (1) US20020064788A1 (en)
EP (1) EP1301633A1 (en)
AU (1) AU2001278987A1 (en)
CA (1) CA2416708A1 (en)
WO (1) WO2002008466A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016327A1 (en) * 2001-08-14 2003-02-27 Mount Sinai School Of Medicine Use of intrinsic reporters of cell signaling for high content durg profiling and toxicity screening
DE60332948D1 (en) 2002-07-19 2010-07-22 Althea Technologies Inc STRATEGIES FOR GENE EXPRESSION ANALYSIS
US20050208495A1 (en) * 2002-09-17 2005-09-22 Joseph Richard A Real-time detection of nucleic acid reactions
US20050084872A1 (en) * 2003-01-24 2005-04-21 Lum Pek Y. Methods for determining whether an agent possesses a defined biological activity
US20050153304A1 (en) * 2003-04-10 2005-07-14 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Multivariate profiling of complex biological regulatory pathways
US20040220125A1 (en) * 2003-05-02 2004-11-04 Coles John G. Biosynthetic platform for cardioprotective gene expression using immature heart tissue
US20050054599A1 (en) * 2003-05-02 2005-03-10 Coles John G. Biosynthetic platform for cardioprotective stress response in human fetal heart tissue
ATE461292T1 (en) 2003-09-10 2010-04-15 Althea Technologies Inc CREATION OF EXPRESSION PROFILES USING MICROARRAYS
EP1524319A1 (en) * 2003-10-13 2005-04-20 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method of classifying chemical agents and identifying cellular targets thereof
US20070105790A1 (en) * 2004-09-02 2007-05-10 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using Na+/K+ ATPase inhibitors
US20080027010A1 (en) * 2004-09-02 2008-01-31 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using Na+/K+-ATPase inhibitors
WO2006028969A1 (en) * 2004-09-02 2006-03-16 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using na+/k+ atpase inhibitors
EP1789090A2 (en) * 2004-09-02 2007-05-30 Bionaut Pharmaceuticals, Inc. Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors
US20060135468A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using NA+/K+ ATPase inhibitors
US20060135443A1 (en) * 2004-10-18 2006-06-22 Bionaut Pharmaceuticals, Inc. Use of Na*/K*-ATPase inhibitors and antagonists thereof
US7899514B1 (en) * 2006-01-26 2011-03-01 The United States Of America As Represented By The Secretary Of The Army Medical image processing methodology for detection and discrimination of objects in tissue
US8724871B1 (en) 2011-12-14 2014-05-13 Atti International Services Company, Inc. Method and system for identifying anomalies in medical images
US9401021B1 (en) 2011-12-14 2016-07-26 Atti International Services Company, Inc. Method and system for identifying anomalies in medical images especially those including body parts having symmetrical properties
US9779504B1 (en) 2011-12-14 2017-10-03 Atti International Services Company, Inc. Method and system for identifying anomalies in medical images especially those including one of a pair of symmetric body parts
CN112834411B (en) * 2021-01-07 2022-05-27 上海交通大学 Metal nanoprobe applied to mass flow technology, preparation method and application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808532A (en) * 1985-07-01 1989-02-28 The United States Of America As Represented By The United States Department Of Energy Continuous human cell lines and method of making same
US5645988A (en) * 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
WO1992021747A1 (en) * 1991-06-03 1992-12-10 Arch Development Corporation Methods and compositions of genetic stress response systems
AU3609693A (en) * 1992-01-29 1993-09-01 Duke University Method of assaying for the oncogenic state of cells
US5571822A (en) * 1994-09-30 1996-11-05 The University Of North Carolina At Chapel Hill Antitumor compounds
US5759836A (en) * 1995-03-27 1998-06-02 Hospital For Joint Diseases Osteoarthritis-associated inducable isoform of nitric oxide synthetase
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5747338A (en) * 1996-08-15 1998-05-05 Chiron Corporation Method and construct for screening for inhibitors of transcriptional activation
US6165709A (en) * 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
US5807740A (en) * 1997-04-25 1998-09-15 Tularik Inc. Regulators of UCP2 gene expression

Also Published As

Publication number Publication date
EP1301633A1 (en) 2003-04-16
WO2002008466A9 (en) 2003-05-22
CA2416708A1 (en) 2002-01-31
WO2002008466A1 (en) 2002-01-31
US20020064788A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
AU4125001A (en) Computer case
AU2001278987A1 (en) A systematic approach to mechanism-of-response analyses
AU2001282408A1 (en) A structural module
AU2001287175A1 (en) Achieving a relaxed state
AU2001282703A1 (en) Intervention module for a well
AU2001264964A1 (en) Cross-reference to related applications
AU2001231524A1 (en) Pointing means for a computer
EP1223498A3 (en) A computer housing
AU2002220221A1 (en) Fixed cursor
AU2001210409A1 (en) Touchpad
AU2001252367A1 (en) Improvements relating to computer systems
AU2001216907A1 (en) A honeycomb paenl assembly
AUPQ584700A0 (en) A heatsink unit
AU2001264882A1 (en) Watchdog arrangement
AU2001296039A1 (en) Computer
AU2000273277A1 (en) A grid structure
AU2001255081A1 (en) Mouse
AUPQ867600A0 (en) A filter assembly
AU2001247542A1 (en) A systematic approach to the analysis of gene function
AU2001267355A1 (en) A reactor
AU2001290112A1 (en) Computer instructions
EP1223499B8 (en) Computer
AU2002314075A1 (en) Multifunctional computer
AU2001252821A1 (en) A sawweb arrangement for fungus-control
AUPQ645400A0 (en) A ligand - II